MAGE-3 peptides presented by HLA class II molecules

Details MAGE-3 peptides presented by HLA class II molecules MAGE-3 peptides presented by HLA class II molecules

2007-08-07

2007-08-07

Foley, Shanon (Department: 1642)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S277100, C424S093100

Reexamination Certificate

active

10170832

ABSTRACT:
The invention describes HLA class II binding peptides encoded by the MAGE-3 tumor associated gene, as well as nucleic acids encoding such peptides and antibodies relating thereto. The peptides stimulate the activity and proliferation of CD4+T lymphocytes. Methods and products also are provided for diagnosing and treating conditions characterized by expression of the MAGE-3 gene.

REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
patent: 92/04354 (1992-11-01), None
Burgess et al. J of Cell Bio. 1990. vol. 111:2129-2138.
Bowie et al. Science. 1990. vol. 247:1306-1310.
Chaux et al, (Int J Cancer, 1998, 77: 538-542).
Sherman et al, (Critical Reviews in Immunol, 1998, 18:47-54).
Smith (Clin Immunol, 1994, 41(4): 841-849).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Sant'Angelo et al (Eur J Immunol, 2002, 32:250-2520).
De Plaen et al.,Immunogenetics40:360-369 (1994).
Traversari et al.,Immunogenetics35:1643 (1991).
Van Der Bruggen et al.,Science254:1643 (1991).

Affiliated with

Also associated with

Rating

MAGE-3 peptides presented by HLA class II molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MAGE-3 peptides presented by HLA class II molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MAGE-3 peptides presented by HLA class II molecules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3837826